
CMIC Group Supports Clinical Trials and Manufacturing of Influenza Antiviral Drug “Avigan® Tablet” and Contributes to Accelerating Provision for COVID-19 Patients TOKYO–(BUSINESS WIRE)–CMIC HOLDINGS Co., Ltd. (Head Office: Tokyo, Minato-ku, Representative Director & CEO Kazuo Nakamura, hereafter “CMIC”) announced today that CMIC is providing monitoring services as a CRO (Contract Research Organization) for “Avigan® Tablet” (generic […]



